Clinical Scorecard: SSc May Be Linked to Subtle Cognitive Changes
At a Glance
| Category | Detail |
|---|---|
| Condition | Systemic Sclerosis (SSc) |
| Key Mechanisms | Differences in specific cognitive domains, particularly executive functions, with higher anxiety levels. |
| Target Population | Patients with systemic sclerosis compared to healthy controls and patients with rheumatoid arthritis. |
| Care Setting | Clinical research setting |
Key Highlights
- Patients with SSc show subtle cognitive differences rather than global impairment.
- 53% of SSc patients scored below the normal cognition threshold on MoCA.
- SSc patients required more time on executive function tasks compared to controls.
- Higher anxiety levels observed in SSc patients, particularly for trait anxiety.
- Cognitive performance correlated with age, sex, alcohol intake, and SSc interstitial lung disease.
Guideline-Based Recommendations
Diagnosis
- Utilize standardized cognitive tests such as MoCA, TMT, and VST for assessment.
Management
- Monitor cognitive function and anxiety levels in patients with SSc.
Monitoring & Follow-up
- Regularly assess cognitive performance and anxiety symptoms.
Risks
- Consider potential cognitive domain-specific impairments in SSc patients.
Patient & Prescribing Data
Patients diagnosed with systemic sclerosis.
Focus on managing anxiety and monitoring cognitive function.
Clinical Best Practices
- Incorporate cognitive assessments in routine evaluations for SSc patients.
- Address anxiety symptoms as part of comprehensive care for SSc.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
